Non-coding RNAs: Emerging Regulators of Sorafenib Resistance in Hepatocellular Carcinoma

As the first oral multi-target anti-tumor drug proved for the treatment of patients with advanced liver cancer in 2007, sorafenib has changed the landscape of advanced hepatocellular carcinoma (HCC) treatment. However, drug resistance largely hinders its clinical application. Non-coding RNAs (ncRNAs...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Front Oncol
Главные авторы: Lai, Yongting, Feng, Bing, Abudoureyimu, Mubalake, Zhi, Yingru, Zhou, Hao, Wang, Ting, Chu, Xiaoyuan, Chen, Ping, Wang, Rui
Формат: Artigo
Язык:Inglês
Опубликовано: Frontiers Media S.A. 2019
Предметы:
Oncology
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC6848262/
https://ncbi.nlm.nih.gov/pubmed/31750247
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2019.01156
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы